heartburn with glp-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Blood Pressure-Lowering Effects of SGLT2

Patients on monthly dosing would generate less medical waste from syringes and pen devices

The dose can then be increased by 2.5 mg every 4 weeks or more, as tolerated, to a maximum of 15 mg weekly

These factors include age, sex, existing comorbidities, targeted symptoms, blood biomarkers, and specific treatment protocols, before fully endorsing the use of omega-3 PUFAs either as an independent treatment or in conjunction with other medications for migraine management (80)

GLP-1 RAs reduce cardiovascular risks but may cause nausea and GI issues

R Project for Statistical Computing, Vienna, Austria Park MJ, Sohrabji F (2016) The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats

Li J, Miao B, Wang S, Dong W, Xu H, Si C, et al